Novavax - Vergessene Aktie feiert ein Comeback. Gute Chancen dank aktueller Nachrichtenlage (Seite 2251)
eröffnet am 25.04.09 09:22:26 von
neuester Beitrag 16.06.24 00:22:05 von
neuester Beitrag 16.06.24 00:22:05 von
Beiträge: 23.723
ID: 1.149.910
ID: 1.149.910
Aufrufe heute: 12
Gesamt: 1.281.683
Gesamt: 1.281.683
Aktive User: 0
ISIN: US6700024010 · WKN: A2PKMZ · Symbol: NVAX
13,446
EUR
-4,08 %
-0,572 EUR
Letzter Kurs 14.06.24 Tradegate
Neuigkeiten
TitelBeiträge |
---|
13.06.24 · Felix Haupt Anzeige |
07.06.24 · LYNX Analysen Anzeige |
23.05.24 · wallstreetONLINE Redaktion |
Shortseller bluten: Novavax: Aktie steigt um weitere 50 Prozent – Sanofi-Deal leitet Turnaround ein! 14.05.24 · wallstreetONLINE Redaktion |
Werte aus der Branche Biotechnologie
Wertpapier | Kurs | Perf. % |
---|---|---|
0,8000 | +2.566,67 | |
3,3000 | +44,74 | |
1,2200 | +31,76 | |
1,2450 | +29,69 | |
7,7600 | +29,33 |
Wertpapier | Kurs | Perf. % |
---|---|---|
2,7900 | -24,80 | |
1,0100 | -26,81 | |
9,5300 | -34,00 | |
1,2400 | -34,39 | |
1,0950 | -34,43 |
Beitrag zu dieser Diskussion schreiben
Ich denke wir sehen hier bald die 35-40 Euro wieder. Bei Massenimpfungen ist das die Systemisch best aufgestellte Firma. es geht sicher noch 2-3 Monate bis die Impfungen parat sind aber Novavax wird mit dabei sein.
Heute Gewinne mitnehmen. Am Montag ist China wieder am Markt.
Die Aktiem kommt von über 40 € vor einem Jahr... Wiederauferstehung?
https://www.wallstreet-online.de/aktien/novavax-3-aktie#t:3y…
https://www.wallstreet-online.de/aktien/novavax-3-aktie#t:3y…
Andere entwickeln Medikamente, Novavax den Impfstoff, Potential sicher noch 100% plus X
Coronavirus-Impfstoff wird in Tierversuchen angewendet:
Novavax Begins Animal Testing for Coronavirus Vaccine Candidate
Novavax says it's ready to advance its vaccine candidate to Phase I clinical testing in May or June.
Tony Owusu
13 minutes ago
Novavax (NVAX) - Get Report shares jumped Thursday after the company announced that it was beginning animal testing for its potential coronavirus vaccine candidates with plans to use those tests to determine which would be best suited to try on humans.
The company developed the candidates using its proprietary recombinant protein nanoparticle technology platform.
“Our previous experience working with other coronaviruses, including both MERS and SARS, allowed us to mobilize quickly against Covid-19 and successfully complete the critical preliminary steps to engineer viable vaccine candidates,” said CEO Stanley C. Erck.
Novavax touted its “proven track record” of producing rapid innovative vaccines against previous coronaviruses, including Middle East Respiratory Syndrome (MERS) andSevere Acute Respiratory Syndrome (SARS).
“We are now well-positioned to advance the Covid-19 vaccine candidate to Phase I clinical testing in May or June,” Erck said.
Novavax was gaining more than 24% to $11.50 in trading Thursda
Novavax Begins Animal Testing for Coronavirus Vaccine Candidate
Novavax says it's ready to advance its vaccine candidate to Phase I clinical testing in May or June.
Tony Owusu
13 minutes ago
Novavax (NVAX) - Get Report shares jumped Thursday after the company announced that it was beginning animal testing for its potential coronavirus vaccine candidates with plans to use those tests to determine which would be best suited to try on humans.
The company developed the candidates using its proprietary recombinant protein nanoparticle technology platform.
“Our previous experience working with other coronaviruses, including both MERS and SARS, allowed us to mobilize quickly against Covid-19 and successfully complete the critical preliminary steps to engineer viable vaccine candidates,” said CEO Stanley C. Erck.
Novavax touted its “proven track record” of producing rapid innovative vaccines against previous coronaviruses, including Middle East Respiratory Syndrome (MERS) andSevere Acute Respiratory Syndrome (SARS).
“We are now well-positioned to advance the Covid-19 vaccine candidate to Phase I clinical testing in May or June,” Erck said.
Novavax was gaining more than 24% to $11.50 in trading Thursda
Shares of Novavax (NASDAQ:NVAX) were up 18.1% as of 10:32 a.m. EST on Wednesday after rising as much as 41% earlier in the day. The big jump came after the biotech announced plans to begin clinical testing by late spring for an experimental vaccine to protect individuals against COVID-19, the disease caused by the novel coronavirus that's causing major health concerns across the world.
Vielleicht auch ganz interessant, für alle die in Coronavirus-Aktien zocken: Co-Diagnostics A2DU6V. Meldung vor 1 oder 2 Tagen, dass Coronavirus-Test entwickelt wurde...
Co-Diagnostics: Vielleicht auch ganz interessant für alle, die in Coronavirus-Aktien spekulieren.
https://www.wallstreet-online.de/nachricht/12091233-co-diagn…
https://www.wallstreet-online.de/nachricht/12091233-co-diagn…
Gregory Glenn von "Novavax" im Interview vom 23. Januar 2020
https://aktien-boersen.blogspot.com/2020/01/gregory-glenn-vo…
https://aktien-boersen.blogspot.com/2020/01/gregory-glenn-vo…
Totgesagte leben länger oder das letzte Zucken vor dem Ende? Wundertüte Novavax.
23.05.24 · wallstreetONLINE Redaktion · Pfizer |
Shortseller bluten: Novavax: Aktie steigt um weitere 50 Prozent – Sanofi-Deal leitet Turnaround ein! 14.05.24 · wallstreetONLINE Redaktion · Sanofi |
13.05.24 · Der Aktionär TV · Apple |
10.05.24 · dpa-AFX · McDonald's |
10.05.24 · dpa-AFX · 3M |
10.05.24 · dpa-AFX · Enel |
10.05.24 · dpa-AFX · 3M |
10.05.24 · dpa-AFX · Sanofi |